141 related articles for article (PubMed ID: 17290530)
1. Potent statin goes generic.
Johns Hopkins Med Lett Health After 50; 2006 Dec; 18(10):7. PubMed ID: 17290530
[No Abstract] [Full Text] [Related]
2. [Pfizer: TLV decision about antilipemic agents is founded on wrong basis].
Brun J; Ohlsson-Onerud A; Sörensen N
Lakartidningen; 2009 Apr 22-28; 106(17):1193-4; discussion 1194. PubMed ID: 19530431
[No Abstract] [Full Text] [Related]
3. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
Sedjo RL; Cox ER
Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
[TBL] [Abstract][Full Text] [Related]
4. A switch in time saves more than nine. Two popular statins, Pravachol and Zocor, go generic this summer, paving the way for significant savings.
Harv Heart Lett; 2006 May; 16(9):1-2. PubMed ID: 16688877
[No Abstract] [Full Text] [Related]
5. Increasing the availability of generics.
FDA Consum; 2006; 40(5):3. PubMed ID: 17326300
[No Abstract] [Full Text] [Related]
6. [Statin--who can make out the prices?].
Heebøll-Nielsen NC
Ugeskr Laeger; 2003 Aug; 165(32):3100. PubMed ID: 12951858
[No Abstract] [Full Text] [Related]
7. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
Tran YB; Frial T; Miller PS
Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788
[TBL] [Abstract][Full Text] [Related]
8. Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugs.
Cahn LJ
Manag Care; 2010 Nov; 19(11):21-7. PubMed ID: 21141372
[No Abstract] [Full Text] [Related]
9. Out-of-pocket costs to users: medicine options for hypertension.
Arredondo A
Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
[No Abstract] [Full Text] [Related]
10. [Medication supply of privately insured patients in 2010].
Wild F
Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
[No Abstract] [Full Text] [Related]
11. [The state is losing money on the generic drug exchange].
Lones O
Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3154. PubMed ID: 16299582
[No Abstract] [Full Text] [Related]
12. Drug use review matters.
Mueting M
Nebr Nurse; 2007; 40(3):28. PubMed ID: 17915614
[No Abstract] [Full Text] [Related]
13. Lipitor goes generic: business as usual or more big business?
Gill L; Santa J; Peter DL; Keehn J
Ann Intern Med; 2012 Jun; 156(12):892-3, W313. PubMed ID: 22711082
[No Abstract] [Full Text] [Related]
14. Increasing generic drug use in Medicare Part D: the role of government.
Kohl H; Shrank WH
J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
[No Abstract] [Full Text] [Related]
15. RE: M Thomas. The change of cost: reference-based pricing and the statins. 1999;15:535-8.
McNee W
Can J Cardiol; 1999 Nov; 15(11):1287. PubMed ID: 10841625
[No Abstract] [Full Text] [Related]
16. Switching statins: cost of simvastatin is overestimated.
Ashcroft JS
BMJ; 2006 Jun; 332(7556):1512. PubMed ID: 16793831
[No Abstract] [Full Text] [Related]
17. Is There a Cure for High Drug Prices? A Special Investigation From Consumer Reports Best Buy Drugs.
Consum Rep; 2016 Aug; 81(8):52-60. PubMed ID: 27459753
[No Abstract] [Full Text] [Related]
18. Recently introduced generics helped PBM control its costs.
Manag Care; 2005 Nov; 14(11):77. PubMed ID: 16350653
[No Abstract] [Full Text] [Related]
19. The MDA's prescription coverage and generic drugs.
Stafford E
J Mich Dent Assoc; 2010 May; 92(5):18. PubMed ID: 20536070
[No Abstract] [Full Text] [Related]
20. The change of cost: reference-based pricing and the statins.
Thomas M
Can J Cardiol; 1999 May; 15(5):535-8. PubMed ID: 10350662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
